Long-term results from testicular cancer treatment are positive, study shows

byUniversity College CorkCredit: Pixabay/CC0 Public DomainA new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even aft

Updated on: August 03,2024

Long-term results from testicular cancer treatment are positive, study shows

byUniversity College CorkCredit: Pixabay/CC0 Public DomainA new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even aft

Updated on:August 03,2024

Study suggests lymphoma patients with depression or anxiety experience shorter survival times

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with depression and/or anxiety prior to a diagnosis of diffuse large B-cell lymphoma (DLBCL) had shorter survival times t

Updated on: January 22,2024

Study suggests lymphoma patients with depression or anxiety experience shorter survival times

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with depression and/or anxiety prior to a diagnosis of diffuse large B-cell lymphoma (DLBCL) had shorter survival times t

Updated on:January 22,2024

Targeting cancer's hidden master regulators

by Columbia University Irving Medical CenterSchematic of the VIPER (A), OncoTarget (B), and OncoTreat (C) methodologies. G.E.S.: gene expression signature. MoR: mode of regulation—i.e., genes who

Updated on: April 14,2024

Targeting cancer's hidden master regulators

by Columbia University Irving Medical CenterSchematic of the VIPER (A), OncoTarget (B), and OncoTreat (C) methodologies. G.E.S.: gene expression signature. MoR: mode of regulation—i.e., genes who

Updated on:April 14,2024

Serendipity reveals new method to fight cancer with T cells

by Laura Red Eagle,University of Wisconsin-MadisonGraphical abstract. Credit:Molecular Therapy - Methods & Clinical Development(2024). DOI: 10.1016/j.omtm.2024.101249A promising

Updated on: July 05,2024

Serendipity reveals new method to fight cancer with T cells

by Laura Red Eagle,University of Wisconsin-MadisonGraphical abstract. Credit:Molecular Therapy - Methods & Clinical Development(2024). DOI: 10.1016/j.omtm.2024.101249A promising

Updated on:July 05,2024

Clinical trial could lead to new 'gold standard' test for prostate cancer detection

by Gillian Rutherford,University of AlbertaCredit: MART PRODUCTION from PexelsA University of Alberta study shows that PET/CT imaging using a new tracing agent is more accurate at determining th

Updated on: July 05,2024

Clinical trial could lead to new 'gold standard' test for prostate cancer detection

by Gillian Rutherford,University of AlbertaCredit: MART PRODUCTION from PexelsA University of Alberta study shows that PET/CT imaging using a new tracing agent is more accurate at determining th

Updated on:July 05,2024

Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainColorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer d

Updated on: February 18,2024

Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainColorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer d

Updated on:February 18,2024

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on: November 09,2024

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on:November 09,2024

Breast cancer recurrence rate not up with autologous fat transfer

(HealthDay)—For patients with breast cancer, reconstruction with autologous fat transfer (AFT) seems not to increase the rate of locoregional recurrence versus conventional breast reconstruction, acco

Updated on: April 01,2024

Breast cancer recurrence rate not up with autologous fat transfer

(HealthDay)—For patients with breast cancer, reconstruction with autologous fat transfer (AFT) seems not to increase the rate of locoregional recurrence versus conventional breast reconstruction, acco

Updated on:April 01,2024

Researchers combine CRISPR gene-editing technology with drug discovery to understand why cancer treatment works

by Caitlin Mcdermott-Murphy,Harvard UniversityCancerous cells (dark purple) start to spread in a patient's bone marrow. Mutated genes often spark rampant AML cancer growth. Credit: The Armed

Updated on: June 15,2024

Researchers combine CRISPR gene-editing technology with drug discovery to understand why cancer treatment works

by Caitlin Mcdermott-Murphy,Harvard UniversityCancerous cells (dark purple) start to spread in a patient's bone marrow. Mutated genes often spark rampant AML cancer growth. Credit: The Armed

Updated on:June 15,2024

Sharp pain in your feet? Researchers test promising therapy for cancer patients' neuropathy

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainA wearable, app-controlled wireless device that stimulates nerves in the legs and feet may help individuals

Updated on: April 09,2024

Sharp pain in your feet? Researchers test promising therapy for cancer patients' neuropathy

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainA wearable, app-controlled wireless device that stimulates nerves in the legs and feet may help individuals

Updated on:April 09,2024

New computational tool identifies novel targets for cancer immunotherapy

byChildren's Hospital of PhiladelphiaIRIS: A big-data informed computational platform for discovering AS-derived cancer immunotherapy targets. Overall workflow of IRIS, computational modules

Updated on: January 12,2024

New computational tool identifies novel targets for cancer immunotherapy

byChildren's Hospital of PhiladelphiaIRIS: A big-data informed computational platform for discovering AS-derived cancer immunotherapy targets. Overall workflow of IRIS, computational modules

Updated on:January 12,2024

Researchers develop AI-driven tool for near real-time cancer surveillance

by Mark Alewine,Oak Ridge National LaboratoryCancer cell during cell division. Credit: National Institutes of HealthArtificial intelligence has delivered a major win for pathologists and researc

Updated on: March 20,2024

Researchers develop AI-driven tool for near real-time cancer surveillance

by Mark Alewine,Oak Ridge National LaboratoryCancer cell during cell division. Credit: National Institutes of HealthArtificial intelligence has delivered a major win for pathologists and researc

Updated on:March 20,2024